In addition, we observed that treatment of breast cancer cell lines in vitro with anti-cancer drugs routinely used in the clinic to treat breast cancers (doxorubicin, mitoxantrone and 5-flurouracil) also increased the expression of ABCC1 and ABCC3 in these cells. This evidence concerns the gene ABCC3 and breast carcinoma.